255 related articles for article (PubMed ID: 22718818)
1. DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.
Kosinska AD; Johrden L; Zhang E; Fiedler M; Mayer A; Wildner O; Lu M; Roggendorf M
J Virol; 2012 Sep; 86(17):9297-310. PubMed ID: 22718818
[TBL] [Abstract][Full Text] [Related]
2. Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.
Kosinska AD; Zhang E; Johrden L; Liu J; Seiz PL; Zhang X; Ma Z; Kemper T; Fiedler M; Glebe D; Wildner O; Dittmer U; Lu M; Roggendorf M
PLoS Pathog; 2013; 9(6):e1003391. PubMed ID: 23785279
[TBL] [Abstract][Full Text] [Related]
3. Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.
Lu M; Isogawa M; Xu Y; Hilken G
J Virol; 2005 May; 79(10):6368-76. PubMed ID: 15858020
[TBL] [Abstract][Full Text] [Related]
4. Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope.
Menne S; Maschke J; Tolle TK; Lu M; Roggendorf M
J Virol; 1997 Jan; 71(1):65-74. PubMed ID: 8985324
[TBL] [Abstract][Full Text] [Related]
5. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.
Lu M; Hilken G; Kruppenbacher J; Kemper T; Schirmbeck R; Reimann J; Roggendorf M
J Virol; 1999 Jan; 73(1):281-9. PubMed ID: 9847331
[TBL] [Abstract][Full Text] [Related]
6. Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8
Chiale C; Moshkani S; Rose JK; Robek MD
Antiviral Res; 2019 Aug; 168():156-167. PubMed ID: 31153968
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of gamma interferon with DNA vaccine expressing woodchuck hepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection.
Siegel F; Lu M; Roggendorf M
J Virol; 2001 Jun; 75(11):5036-42. PubMed ID: 11333883
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model.
Lu M; Roggendorf M
Intervirology; 2001; 44(2-3):124-31. PubMed ID: 11509873
[TBL] [Abstract][Full Text] [Related]
9. Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.
Liu KH; Ascenzi MA; Bellezza CA; Bezuidenhout AJ; Cote PJ; Gonzalez-Aseguinolaza G; Hannaman D; Luxembourg A; Evans CF; Tennant BC; Menne S
J Virol; 2011 May; 85(10):4853-62. PubMed ID: 21389124
[TBL] [Abstract][Full Text] [Related]
10. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
Wang J; Gujar SA; Cova L; Michalak TI
J Virol; 2007 Jan; 81(2):903-16. PubMed ID: 17079319
[TBL] [Abstract][Full Text] [Related]
11. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
12. Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection.
Schödel F; Neckermann G; Peterson D; Fuchs K; Fuller S; Will H; Roggendorf M
Vaccine; 1993; 11(6):624-8. PubMed ID: 8322485
[TBL] [Abstract][Full Text] [Related]
13. DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.
Yin Y; Wu C; Song J; Wang J; Zhang E; Liu H; Yang D; Chen X; Lu M; Xu Y
PLoS One; 2011; 6(7):e22524. PubMed ID: 21799884
[TBL] [Abstract][Full Text] [Related]
14. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
15. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
[TBL] [Abstract][Full Text] [Related]
16. Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver.
Obeng-Adjei N; Choo DK; Saini J; Yan J; Pankhong P; Parikh A; Chu JS; Weiner DB
Cancer Gene Ther; 2012 Nov; 19(11):779-87. PubMed ID: 23037809
[TBL] [Abstract][Full Text] [Related]
17. Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12.
García-Navarro R; Blanco-Urgoiti B; Berraondo P; Sánchez de la Rosa R; Vales A; Hervás-Stubbs S; Lasarte JJ; Borrás F; Ruiz J; Prieto J
J Virol; 2001 Oct; 75(19):9068-76. PubMed ID: 11533170
[TBL] [Abstract][Full Text] [Related]
18. Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus.
Fiedler M; Kosinska A; Schumann A; Brovko O; Walker A; Lu M; Johrden L; Mayer A; Wildner O; Roggendorf M
J Virol; 2013 Jul; 87(13):7708-16. PubMed ID: 23637419
[TBL] [Abstract][Full Text] [Related]
19. Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccination.
Brass A; Frelin L; Milich DR; Sällberg M; Ahlén G
Mol Ther; 2015 Mar; 23(3):578-90. PubMed ID: 25492563
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens.
Chuai X; Chen P; Chen H; Wang W; Deng Y; Ruan L; Li W; Tan W
J Viral Hepat; 2017 Apr; 24(4):337-345. PubMed ID: 27885748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
